Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selincro in Primary Care for Alcohol Dependence
NCT02195817Phase 4Terminated
- Sponsor
- Lundbeck
- Start
- Aug 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of nalmefene in alcohol dependence, sponsored by Lundbeck. Started Aug 2014; status: terminated.
02
Drugs
nalmefene
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT02195817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195817.